Literature DB >> 34932184

Classical risk factors for primary coronary artery disease from an aging perspective through Mendelian Randomization.

Swetta A Jansen1,2, Bas Huiskens2, Stella Trompet1, JWouter Jukema3,4, Simon P Mooijaart1, Ko Willems van Dijk5,6,7, Diana van Heemst1, Raymond Noordam8.   

Abstract

The significance of classical risk factors in coronary artery disease (CAD) remains unclear in older age due to possible changes in underlying disease pathologies. Therefore, we conducted Mendelian Randomization approaches to investigate the causal relationship between classical risk factors and primary CAD in different age groups. A Mendelian Randomization study was conducted in European-ethnicity individuals from the UK Biobank population. Analyses were performed using data of 22,313 CAD cases (71.6% men) and 407,920 controls (44.5% men). Using logistic regression analyses, we investigated the associations between standardized genetic risk score and primary CAD stratified by age of diagnosis. In addition, feature importance and model accuracy were assessed in different age groups to evaluate predictive power of the genetic risk scores with increasing age. We found age-dependent associations for all classical CAD risk factors. Notably, body mass index (OR 1.22 diagnosis < 50 years; OR 1.02 diagnosis > 70 years), blood pressure (OR 1.12 < 50 years; OR 1.04 > 70 years), LDL cholesterol (OR 1.16 < 50 years; OR 1.02 > 70 years), and triglyceride levels (OR 1.11 < 50 years; 1.04 > 70 years). In line with the Mendelian Randomization analyses, model accuracy and feature importance of the classical risk factors decreased with increasing age of diagnosis. Causal determinants for primary CAD are age dependent with classical CAD risk factors attenuating in relation with primary CAD with increasing age. These results question the need for (some) currently applied cardiovascular disease risk reducing interventions at older age.
© 2021. The Author(s), under exclusive licence to American Aging Association.

Entities:  

Keywords:  Aging; Coronary artery disease; LDL cholesterol; Mendelian Randomization; Risk factors

Mesh:

Year:  2021        PMID: 34932184      PMCID: PMC9213623          DOI: 10.1007/s11357-021-00498-9

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.581


  30 in total

1.  Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites.

Authors:  Ines Florath; Katja Butterbach; Heiko Müller; Melanie Bewerunge-Hudler; Hermann Brenner
Journal:  Hum Mol Genet       Date:  2013-10-26       Impact factor: 6.150

2.  Antihypertensive Agents in Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Mohammad Hassan Murad; Laura Larrea-Mantilla; Abdullah Haddad; Gabriela Spencer-Bonilla; Valentina Serrano; Rene Rodriguez-Gutierrez; Neri Alvarez-Villalobos; Khaled Benkhadra; Michael R Gionfriddo; Larry J Prokop; Juan P Brito; Oscar J Ponce
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

Review 3.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

4.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

Authors:  James Shepherd; Gerard J Blauw; Michael B Murphy; Edward L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Ian Ford; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; A Edo Meinders; John Norrie; Chris J Packard; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

5.  Blood pressure and risk of myocardial infarction in elderly men and women: the Rotterdam study.

Authors:  P C van den Hoogen; N M van Popele; E J Feskens; D A van der Kuip; D E Grobbee; A Hofman; J C Witteman
Journal:  J Hypertens       Date:  1999-10       Impact factor: 4.844

6.  Arterial stiffness and cardiovascular events: the Framingham Heart Study.

Authors:  Gary F Mitchell; Shih-Jen Hwang; Ramachandran S Vasan; Martin G Larson; Michael J Pencina; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Emelia J Benjamin
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

7.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

Review 8.  Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis.

Authors:  Chenhan Ma; Alison Avenell; Mark Bolland; Jemma Hudson; Fiona Stewart; Clare Robertson; Pawana Sharma; Cynthia Fraser; Graeme MacLennan
Journal:  BMJ       Date:  2017-11-14

9.  The relationship of DNA methylation with age, gender and genotype in twins and healthy controls.

Authors:  Marco P Boks; Eske M Derks; Daniel J Weisenberger; Erik Strengman; Esther Janson; Iris E Sommer; René S Kahn; Roel A Ophoff
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

10.  The transcriptional landscape of age in human peripheral blood.

Authors:  Marjolein J Peters; Roby Joehanes; Luke C Pilling; Claudia Schurmann; Karen N Conneely; Joseph Powell; Eva Reinmaa; George L Sutphin; Alexandra Zhernakova; Katharina Schramm; Yana A Wilson; Sayuko Kobes; Taru Tukiainen; Yolande F Ramos; Harald H H Göring; Myriam Fornage; Yongmei Liu; Sina A Gharib; Barbara E Stranger; Philip L De Jager; Abraham Aviv; Daniel Levy; Joanne M Murabito; Peter J Munson; Tianxiao Huan; Albert Hofman; André G Uitterlinden; Fernando Rivadeneira; Jeroen van Rooij; Lisette Stolk; Linda Broer; Michael M P J Verbiest; Mila Jhamai; Pascal Arp; Andres Metspalu; Liina Tserel; Lili Milani; Nilesh J Samani; Pärt Peterson; Silva Kasela; Veryan Codd; Annette Peters; Cavin K Ward-Caviness; Christian Herder; Melanie Waldenberger; Michael Roden; Paula Singmann; Sonja Zeilinger; Thomas Illig; Georg Homuth; Hans-Jörgen Grabe; Henry Völzke; Leif Steil; Thomas Kocher; Anna Murray; David Melzer; Hanieh Yaghootkar; Stefania Bandinelli; Eric K Moses; Jack W Kent; Joanne E Curran; Matthew P Johnson; Sarah Williams-Blangero; Harm-Jan Westra; Allan F McRae; Jennifer A Smith; Sharon L R Kardia; Iiris Hovatta; Markus Perola; Samuli Ripatti; Veikko Salomaa; Anjali K Henders; Nicholas G Martin; Alicia K Smith; Divya Mehta; Elisabeth B Binder; K Maria Nylocks; Elizabeth M Kennedy; Torsten Klengel; Jingzhong Ding; Astrid M Suchy-Dicey; Daniel A Enquobahrie; Jennifer Brody; Jerome I Rotter; Yii-Der I Chen; Jeanine Houwing-Duistermaat; Margreet Kloppenburg; P Eline Slagboom; Quinta Helmer; Wouter den Hollander; Shannon Bean; Towfique Raj; Noman Bakhshi; Qiao Ping Wang; Lisa J Oyston; Bruce M Psaty; Russell P Tracy; Grant W Montgomery; Stephen T Turner; John Blangero; Ingrid Meulenbelt; Kerry J Ressler; Jian Yang; Lude Franke; Johannes Kettunen; Peter M Visscher; G Gregory Neely; Ron Korstanje; Robert L Hanson; Holger Prokisch; Luigi Ferrucci; Tonu Esko; Alexander Teumer; Joyce B J van Meurs; Andrew D Johnson
Journal:  Nat Commun       Date:  2015-10-22       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.